• Tobramycin was administered intravenously to guinea pigs and was shown to produce an impairment of the alternating current cochlear potential. This effect is temporary and occurs only when the blood pressure has been severely lowered. We conclude that these data do not represent the onset of ototoxicity of tobramycin as reported by others, but only represents the cochlear effect of the pronounced fall in blood pressure that is produced by the tobramycin.
(Arch Otolaryngol 101:540-543, 1975)
Brummett RE, Brown RT. Tobramycin Ototoxicity: A Second Look. Arch Otolaryngol. 1975;101(9):540–543. doi:10.1001/archotol.1975.00780380018004
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.